Development and Validation of Nomogram for the Prediction of Malignant Ventricular Arrhythmia Including Circulating Inflammatory Cells in Patients with Acute ST-Segment Elevation Myocardial Infarction
Liang Wang,Liting Yang,Tao Li,Shanshan Geng
DOI: https://doi.org/10.2147/jir.s420305
IF: 4.5
2023-07-28
Journal of Inflammation Research
Abstract:Liang Wang, Liting Yang, Tao Li, Shanshan Geng Department of Cardiology, Shuyang Hospital of Traditional Chinese Medicine, Shuyang, Jiangsu, People's Republic of China Correspondence: Shanshan Geng, Department of Cardiology, Shuyang Hospital of Traditional Chinese Medicine, No. 28, Shanghai Road, Shuyang, Jiangsu, 223600, People's Republic of China, Tel + 86-052783562463, Email Background: Malignant ventricular arrhythmia (MVA) can seriously affect the hemodynamic changes of the body. In this study, we developed and validated a nomogram to predict the in-hospital MVA risk in patients with STEMI after emergency PCI. Methods: The multivariable logistic regression analysis included variables with a P< 0.05 in the univariate logistic regression analysis and investigated the independent predictors affecting in-hospital MVA after PCI in patients with STEMI in the training cohort. The construction of a nomogram model used independent predictors to predict the risk of in-hospital MVA, and C-index, Hosmer-Lemeshow (HL) test, calibration curves, decision curve analysis (DCA), and receiver operating characteristic (ROC) were used to validate the nomogram. Results: Killip class [OR=5.034 (95% CI: 1.596– 15.809), P=0.005], CK-MB [OR=1.002 (95% CI: 1.001– 1.004), P=0.022], serum potassium [OR=0.618 (95% CI: 0.406– 0.918), P=0.020], NLR [OR=1.073 (95% CI: 1.034– 1.115), P< 0.001], and monocyte [OR=1.974 (95% CI: 1.376– 2.925), P< 0.001] were the independent predictors of in-hospital MVA after PCI in patients with STEMI. A nomogram including the 5 independent predictors was developed to predict the risk of in-hospital MVA. The C-index, equivalent to the area under the ROC curve (AUC), was 0.803 (95% confidence interval [CI]: 0.738– 0.868) in the training cohort, and 0.801 (95% CI:0.692– 0.911) in the validation cohort, showing that the nomogram had a good discrimination. The HL test ( χ 2 =8.439, P=0.392 in the training cohort; χ 2 =9.730, P=0.285 in the validation cohort) revealed a good calibration. The DCA suggested an obvious clinical net benefit. Conclusion: Killip class, CK-MB, serum potassium, NLR, and monocyte were independent factors for in-hospital MVA after PCI in patients with STEMI. The nomogram model constructed based on the above factors to predict the risk of in-hospital MVA had satisfactory discrimination, calibration, and clinical effectiveness, and was an excellent tool for early prediction of the risk of in-hospital MVA after PCI in patients with STEMI. Keywords: ST-segment elevation myocardial infarction, percutaneous coronary intervention, nomogram model, malignant ventricular arrhythmia, circulating inflammatory cells Ischemic heart disease is a critical cause of death in China, resulting in a large number of deaths and disabilities every year. 1 ST-segment elevation myocardial infarction (STEMI) is a serious condition of ischemic heart disease with high mortality and hospitalization rates. 2 Currently, percutaneous coronary intervention (PCI) is one of the most reliable methods for treating STEMI. 3 PCI allows timely reperfusion of the infarcted vessel, but reperfusion itself can exacerbate myocardial injury and increase the likelihood of malignant ventricular arrhythmia (MVA). As a fatal complication after STEMI, MVA can seriously affect the hemodynamic changes of the body, leading to syncope and even sudden cardiac death. 4 It has been shown that the majority of MVA events occur within 48 hours of the onset of STEMI symptoms and become one of the most common causes of sudden cardiac death in patients during hospitalization. 5,6 Compared with patients without MVA, patients with MVA have a significantly lower 30-day survival rate (69% vs 96%). 7 However, death caused by MVA is often regarded as the first symptom of STEMI, as it is usually sudden and unexpected with no obvious clinical indications, which lead to a possible underestimation of the true burden of MVA. 8 Therefore, identifying high-risk STEMI patients with MVA early in admission and taking effective preventive management measures are crucial for improving the survival of these patients. The development of a convenient and effective prediction model is useful for evaluating the risk of in-hospital MVA after emergency PCI in patients with STEMI and is important for early detection of patients at high risk of MVA and timely intervention. The development of MVA is strongly associated with multiple patient characteristics including low blood pressure, low left ventricular ejection fraction (LVEF), and hypokalemia, creatine kinase-MB (CK-MB), cardiac troponin I (cTnI), creatinine, hyperlipidaemia. 9–15 In addition, previous studies hav -Abstract Truncated-
immunology